Esomeprazole

Chemical formula: C₁₇H₁₉N₃O₃S  Molecular mass: 345.416 g/mol  PubChem compound: 9568614

Therapeutic indications

Esomeprazole is indicated for:

NSAID associated benign gastric and duodenal ulcers

Population group: only adults (18 years old or older)

Healing of gastric ulcers associated with NSAID therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Erosive reflux esophagitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Treatment of erosive reflux esophagitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastroesophageal reflux disease (GERD)

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Symptomatic treatment of gastroesophageal reflux disease (GERD).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of erosive reflux esophagitis relapse

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Long-term management of patients with healed esophagitis to prevent relapse.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Eradication of Helicobacter pylori

Population group: only adults (18 years old or older)

Healing of Helicobacter pylori associated duodenal ulcer.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of relapse of peptic ulcers associated with Helicobacter pylori

Population group: only adults (18 years old or older)

Prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of gastric and duodenal ulcers associated with NSAID therapy

Population group: only adults (18 years old or older)

Prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Zollinger-Ellison syndrome

Population group: only adults (18 years old or older)

Treatment of Zollinger Ellison Syndrome.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Eradication of Helicobacter pylori

Population group: only adolescents (12 years - 18 years old)

Healing of Helicobacter pylori associated duodenal ulcer.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Erosive reflux esophagitis

Population group: only children (1 year - 12 years old)

Treatment of endoscopically proven erosive reflux esophagitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gastroesophageal reflux disease (GERD)

Population group: only children (1 year - 12 years old)

Symptomatic treatment of gastroesophageal reflux disease (GERD).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Eradication of Helicobacter pylori

Population group: only children (1 year - 12 years old)

Healing of Helicobacter pylori associated duodenal ulcer.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of rebleeding of gastric and duodenal ulcers

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Relapse prevention and additionally at least one of
Duodenal ulcer with hemorrhage
Gastric ulcer with hemorrhage

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Esomeprazole is contraindicated in the following cases:

Nelfinavir

Nelfinavir

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.